Cargando…
ICAM-1-suPAR-CD11b Axis Is a Novel Therapeutic Target for Metastatic Triple-Negative Breast Cancer
SIMPLE SUMMARY: The binding of neutrophils with circulating tumor cells (CTCs) enhances the metastatic ability of CTCs. However, the mechanism by which neutrophils bind to CTCs remains elusive. In this study, we found that intercellular adhesion molecule-1 (ICAM-1) on triple-negative breast cancer (...
Autores principales: | Li, Dong, Hemati, Hami, Park, Younhee, Taftaf, Rokana, Zhang, Youbin, Liu, Jinpeng, Cristofanilli, Massimo, Liu, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216673/ https://www.ncbi.nlm.nih.gov/pubmed/37345070 http://dx.doi.org/10.3390/cancers15102734 |
Ejemplares similares
-
suPAR and Team Nephrology
por: Trachtman, Howard
Publicado: (2014) -
suPAR: The Molecular Crystal Ball
por: Thunø, Maria, et al.
Publicado: (2009) -
suPAR: An Inflammatory Mediator for Kidneys
por: Sudhini, Yashwanth Reddy, et al.
Publicado: (2022) -
suPAR as a prognostic biomarker in sepsis
por: Donadello, Katia, et al.
Publicado: (2012) -
Reassessing the Reassessment of suPAR in Glomerular Disease
por: Meijers, Björn K. I., et al.
Publicado: (2015)